Abstract: There is provided a novel sophorolipid derivative having high water solubility and surface activity. A plurality of sophorolipid derivatives having a novel structure is isolated and purified from a cultured product of sophorolipid producing microorganism (Starmerella bombicola, etc.) (wherein, R1 to R3 are each independently hydrogen, a fatty acid ester having 2 to 22 carbon atoms, or the above SL group, provided that at least one of R1 to R3 is the SL group in which R are the same or different and each represent hydrogen or an acetyl group and Rn is a linear or branched alkyl or alkenyl group having 13 to 21 carbon atoms).

Abstract: When a failure occurs in a storage device, a backup unit specifies LUNs of a copy source and a copy destination to an operation volume for which a process is not taken over to another storage device and instructs to perform a copy. When a copy processing unit in the storage device receives a copy process to be performed in the operation volume, the copy processing unit performs the copy process by using the specified LUNs of the copy source and the copy destination. If an error occurs without the copy process being taken over to another storage device due to the occurrence of a failover, the backup unit acquires the LUNs of two volumes of a copy pair and the volumes each constituting each of cluster pairs. Then, the backup unit again performs the copy process by using the acquired LUNs.

Abstract: When a failure occurs in a storage device, a backup unit specifies LUNs of a copy source and a copy destination to an operation volume for which a process is not taken over to another storage device and instructs to perform a copy. When a copy processing unit in the storage device receives a copy process to be performed in the operation volume, the copy processing unit performs the copy process by using the specified LUNs of the copy source and the copy destination. If an error occurs without the copy process being taken over to another storage device due to the occurrence of a failover, the backup unit acquires the LUNs of two volumes of a copy pair and the volumes each constituting each of cluster pairs. Then, the backup unit again performs the copy process by using the acquired LUNs.

Abstract: A seedling pot which uses a laminated sheet having a thermoplastic resin layer with waterproofing properties on at least one surface of a paper base material, and molded so that the inner surface is the thermoplastic resin layer is disclosed. The pot is designed so that the cross-sectional permeability of the paper base material is 100 mg/cm2 or less, and the product of the “load acting on the base/base circumference” and “leg height” is within the range of 3-25 g.

Abstract: An antiviral medicinal composition having spent liquor from kraft pulping and/or processed products thereof (kraft lignin, sulfomethylated and/or sulfopropylated kraft lignin) as major constituents, are effective agents in therapeutic and/or preventive methods against AIDS.

Abstract: Compositions for anti-AIDS virus and other antivirus medicines are disclosed. Included are one having the ingredients other than glycyrrhizin contained in licorice, specifically flavonoids contained in licorice and more specifically not less than one kind of substance selected from a group consisting of liquiritigenin, i-liquiritigenin, liquiritin and i-liquiritin and glycyrrhizin produces allowed to contain not less than 3% of flavonoids contained in licorice based on glycyrrhizin as major constituting elements. Method of preparing said compositions having the filtrate obtained through the ultrafiltration of aqueous extract from licorice using ultrafiltration membrane with a fractionatable molecular weight of 10,000 to 100,000 as an effective ingredient and drugs for the pevention from infection and onset and for the therapy against AIDS used said compositions are also claimed.

Abstract: A composition for anti-AIDS viral and other antiviral medicines having spent liquor from pulping and/or processed products thereof as major constituents and preventive and/or therapeutic method(s) against AIDS viral and other viral infections are presented.